Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 5.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 12.20
  • 52 Week Low: 3.73
  • Currency: UK Pounds
  • Shares Issued: 1,074.16m
  • Volume: 0
  • Market Cap: £56.39m
  • Beta: 0.03

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
82.82% above the market average82.82% above the market average82.82% above the market average82.82% above the market average82.82% above the market average
84.00% above the sector average84.00% above the sector average84.00% above the sector average84.00% above the sector average84.00% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio Not Available

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
40.19% below the market average40.19% below the market average40.19% below the market average40.19% below the market average40.19% below the market average
6.98% above the sector average6.98% above the sector average6.98% above the sector average6.98% above the sector average6.98% above the sector average
Price Chg 3m
27.10% above the market average27.10% above the market average27.10% above the market average27.10% above the market average27.10% above the market average
25.58% above the sector average25.58% above the sector average25.58% above the sector average25.58% above the sector average25.58% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI Not Available
Momentum 20 Not Available

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
63.31% below the market average63.31% below the market average63.31% below the market average63.31% below the market average63.31% below the market average
25.93% above the sector average25.93% above the sector average25.93% above the sector average25.93% above the sector average25.93% above the sector average
ROCE
90.56% above the market average90.56% above the market average90.56% above the market average90.56% above the market average90.56% above the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
68.03% below the market average68.03% below the market average68.03% below the market average68.03% below the market average68.03% below the market average
28.21% below the sector average28.21% below the sector average28.21% below the sector average28.21% below the sector average28.21% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
8.59% below the market average8.59% below the market average8.59% below the market average8.59% below the market average8.59% below the market average
25.93% above the sector average25.93% above the sector average25.93% above the sector average25.93% above the sector average25.93% above the sector average
Operating Profit Loss
81.13% below the market average81.13% below the market average81.13% below the market average81.13% below the market average81.13% below the market average
38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
3.21% above the market average3.21% above the market average3.21% above the market average3.21% above the market average3.21% above the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average
Cash
4.3% below the market average4.3% below the market average4.3% below the market average4.3% below the market average4.3% below the market average
28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
58.08% above the market average58.08% above the market average58.08% above the market average58.08% above the market average58.08% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 5.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 12.20
52 Week Low 3.73
Volume 0
Shares Issued 1,074.16m
Market Cap £56.39m
Beta 0.03

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
2.61% above the market average2.61% above the market average2.61% above the market average2.61% above the market average2.61% above the market average
15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average
Price Trend
91.29% above the market average91.29% above the market average91.29% above the market average91.29% above the market average91.29% above the market average
90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average
Income Not Available
Growth
60.61% above the market average60.61% above the market average60.61% above the market average60.61% above the market average60.61% above the market average
78.57% above the sector average78.57% above the sector average78.57% above the sector average78.57% above the sector average78.57% above the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

STX Key Personnel

CEO Anders Lundstrom

Top of Page